Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel
· Delayed Price · Currency is ILS · Price in ILA 32.20
-1.60 (-4.73%)
At close: Dec 4, 2025
TLV:CBI Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -31.55 | -62.46 | -31.05 | -61.74 | -89.58 | 109.03 | Upgrade
|
| Depreciation & Amortization | 0.23 | 0.28 | 0.53 | 17.64 | 22.51 | 23.87 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 1.57 | - | -22.37 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 26.47 | Upgrade
|
| Loss (Gain) From Sale of Investments | 27 | 36 | -3 | 8.03 | 31.15 | -137.14 | Upgrade
|
| Loss (Gain) on Equity Investments | 13.36 | 28.57 | 17 | 22.39 | 30.81 | 28.94 | Upgrade
|
| Stock-Based Compensation | 0.14 | 0.14 | 0.04 | 5.15 | 5.55 | 5.54 | Upgrade
|
| Other Operating Activities | -14.4 | -8.96 | 6.77 | -31.76 | -43.92 | -65.81 | Upgrade
|
| Change in Accounts Receivable | 0.27 | 0.55 | 1.02 | -6.61 | 2.02 | 3.16 | Upgrade
|
| Change in Inventory | - | - | - | -2.25 | 0.58 | 0.73 | Upgrade
|
| Change in Accounts Payable | - | - | - | -4.2 | 5.5 | -3.82 | Upgrade
|
| Change in Other Net Operating Assets | -0.46 | -0.6 | 0.19 | -7.26 | -5.93 | -1.83 | Upgrade
|
| Operating Cash Flow | -5.42 | -6.48 | -8.51 | -59.04 | -41.33 | -33.23 | Upgrade
|
| Capital Expenditures | - | - | -0.01 | -1.27 | -1.59 | -3.19 | Upgrade
|
| Divestitures | - | - | - | -9.52 | - | -1.48 | Upgrade
|
| Investment in Securities | 3.45 | 17.17 | 6.84 | -0.18 | 80.66 | 74.12 | Upgrade
|
| Other Investing Activities | 1.22 | 2.82 | 0.83 | 0.02 | 0.12 | 1.33 | Upgrade
|
| Investing Cash Flow | 4.67 | 20 | 7.66 | -10.96 | 79.18 | 70.78 | Upgrade
|
| Long-Term Debt Repaid | - | -11.25 | -1.16 | -2.51 | -2.42 | -1.75 | Upgrade
|
| Net Debt Issued (Repaid) | -2.74 | -11.25 | -1.16 | -2.51 | -2.42 | -1.75 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -9.74 | -0.26 | Upgrade
|
| Common Dividends Paid | - | - | - | - | -36 | - | Upgrade
|
| Other Financing Activities | -1.69 | -4.3 | -0.03 | 22.56 | -3.38 | -0.37 | Upgrade
|
| Financing Cash Flow | -4.43 | -15.55 | -1.18 | 20.05 | -51.54 | -2.38 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.05 | 0.26 | 0.32 | 4.33 | -1.42 | -4.57 | Upgrade
|
| Net Cash Flow | -5.13 | -1.78 | -1.71 | -45.61 | -15.11 | 30.61 | Upgrade
|
| Free Cash Flow | -5.42 | -6.48 | -8.52 | -60.31 | -42.92 | -36.41 | Upgrade
|
| Free Cash Flow Margin | - | - | -8190.39% | -16300.00% | -19160.71% | -17675.24% | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.04 | -0.05 | -0.39 | -0.27 | -0.23 | Upgrade
|
| Cash Interest Paid | 1.79 | 4.4 | 0.25 | 0.31 | 0.49 | 0.52 | Upgrade
|
| Cash Income Tax Paid | - | - | - | - | 0.09 | - | Upgrade
|
| Levered Free Cash Flow | -3.44 | -5.94 | -5.44 | 6.26 | 23.33 | 10.79 | Upgrade
|
| Unlevered Free Cash Flow | -3.26 | -3.72 | -3.22 | 8.59 | 24.43 | 10.79 | Upgrade
|
| Change in Working Capital | -0.2 | -0.05 | 1.21 | -20.32 | 2.16 | -1.76 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.